Menu Search
Equities

Medley Inc

3YV:DUS

Medley Inc

Actions
  • Price (EUR)21.80
  • Today's Change1.20 / 5.83%
  • Shares traded25.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medley, Inc. is a Japan-based company mainly engaged in the provision of various Internet services in the medical healthcare field. The Company operates in three business segments. The Human Resources Platform segment is engaged in the operation and provision of a performance-based human resource recruitment system Job Medley for solving the shortage and uneven distribution of human resources in the medical healthcare field. The Medical Platform segment is engaged in the development and provision of an online medical care system CLINICS and a medical information provision system MEDLEY to improve the operational efficiency of medical institutions and improve medical access for patients. The New Development Services segment is engaged in the development of nursing care facilities search site Kaigonohonne.

  • Revenue in JPY (TTM)24.53bn
  • Net income in JPY2.69bn
  • Incorporated2009
  • Employees1.11k
  • Location
    Medley Inc7/8FShin Roppongi Bldg., 7-15-7, RoppongiMINATO-KU 106-6113JapanJPN
  • Phone+81 363721265
  • Websitehttps://www.medley.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		4480:TYO since
announced		Transaction
value
Offshore IncAnnounced30 Sep 202430 Sep 2024Announced-3.52%18.13m
GUPPY's IncAnnounced19 Jan 202419 Jan 2024Announced-13.35%43.05m
Data delayed at least 20 minutes, as of Nov 08 2024 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.